Human ANGPTL3 (Angiopoietin Like Protein 3) ELISA Kit (HUES01555)
- SKU:
- HUES01555
- Product Type:
- ELISA Kit
- Size:
- 96 Assays
- Uniprot:
- Q9Y5C1
- Sensitivity:
- 0.47ng/mL
- Range:
- 0.78-50ng/mL
- ELISA Type:
- Sandwich
- Synonyms:
- ANG-5, ANGPT5, ANL
- Reactivity:
- Human
- Sample Type:
- Serum, plasma and other biological fluids
- Research Area:
- Cardiovascular
Description
Human ANGPTL3 (Angiopoietin Like Protein 3) ELISA Kit
The Human ANGPTL3 (Angiopoietin-Like Protein 3) ELISA Kit is specifically designed for the precise and accurate measurement of ANGPTL3 levels in human samples such as serum, plasma, and cell culture supernatants. With its high sensitivity and specificity, this kit ensures dependable and reproducible results, making it perfect for a broad range of research applications.ANGPTL3 is a key protein that plays a crucial role in lipid metabolism and cardiovascular health. Dysregulation of ANGPTL3 has been linked to conditions such as hypercholesterolemia and cardiovascular diseases, making it an important biomarker for understanding these disorders and exploring potential therapeutic interventions.
With the Human ANGPTL3 ELISA Kit, researchers can gain valuable insights into the role of ANGPTL3 in various physiological and pathological processes, paving the way for advancements in personalized medicine and targeted therapies. Trust in the accuracy and reliability of this ELISA kit for your research needs.
Assay type: | Sandwich |
Format: | 96T |
Assay time: | 4.5h |
Reactivity: | Human |
Detection Method: | Colormetric |
Detection Range: | 0.78-50 ng/mL |
Sensitivity: | 0.47 ng/mL |
Sample Volume Required Per Well: | 100µL |
Sample Type: | Serum, plasma and other biological fluids |
Specificity: | This kit recognizes Human ANGPTL3 in samples. No significant cross-reactivity or interference between Human ANGPTL3 and analogues was observed. |
This ELISA kit uses Sandwich-ELISA as the method. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human ANGPTL3. Standards or samples are added to the appropriate micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human ANGPTL3 and Avidin-Horseradish Peroxidase (HRP) conjugate are added to each micro plate well successively and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human ANGPTL3, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by adding Stop Solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human ANGPTL3. The concentration of Human ANGPTL3 in samples can be calculated by comparing the OD of the samples to the standard curve.
UniProt Protein Function: | ANGPTL3: Defects in ANGPTL3 are the cause of familial hypobetalipoproteinemia type 2 (FHBL2); also called combined hypobetalipoproteinemia familial. FHBL2 is a disorder of lipid metabolism characterized by less than 5th percentile age- and sex-specific levels of low density lipoproteins, and dietary fat malabsorption. Affected individuals present with combined hypolipidemia, consisting of extremely low plasma levels of LDL cholesterol, HDL cholesterol, and triglycerides. |
UniProt Protein Details: | Protein type:Secreted; Cell adhesion; Inhibitor; Motility/polarity/chemotaxis; Secreted, signal peptide Chromosomal Location of Human Ortholog: 1p31. 3 Cellular Component: extracellular space; cell surface Molecular Function:integrin binding; enzyme inhibitor activity; phospholipase inhibitor activity; growth factor activity Biological Process: integrin-mediated signaling pathway; cholesterol metabolic process; phospholipid catabolic process; glycerol metabolic process; cell-matrix adhesion; lipid homeostasis; positive regulation of lipid catabolic process; fatty acid metabolic process; signal transduction; sequestering of lipid; positive regulation of angiogenesis; cholesterol homeostasis; acylglycerol homeostasis; phospholipid metabolic process; artery morphogenesis; negative regulation of lipoprotein lipase activity; positive regulation of cell migration; phospholipid homeostasis Disease: Hypobetalipoproteinemia, Familial, 2 |
NCBI Summary: | This gene encodes a member of a family of secreted proteins that function in angiogenesis. The encoded protein, which is expressed predominantly in the liver, is further processed into an N-terminal coiled-coil domain-containing chain and a C-terminal fibrinogen chain. The N-terminal chain is important for lipid metabolism, while the C-terminal chain may be involved in angiogenesis. Mutations in this gene cause familial hypobetalipoproteinemia type 2. [provided by RefSeq, Aug 2015] |
UniProt Code: | Q9Y5C1 |
NCBI GenInfo Identifier: | 25008126 |
NCBI Gene ID: | 27329 |
NCBI Accession: | Q9Y5C1. 1 |
UniProt Related Accession: | Q9Y5C1 |
Molecular Weight: | ~ 54kDa |
NCBI Full Name: | Angiopoietin-related protein 3 |
NCBI Synonym Full Names: | angiopoietin like 3 |
NCBI Official Symbol: | ANGPTL3 |
NCBI Official Synonym Symbols: | ANL3; ANG-5; FHBL2; ANGPT5 |
NCBI Protein Information: | angiopoietin-related protein 3 |
UniProt Protein Name: | Angiopoietin-related protein 3 |
UniProt Synonym Protein Names: | Angiopoietin-5; ANG-5; Angiopoietin-like protein 3 |
Protein Family: | Angiopoietin-related protein |
UniProt Gene Name: | ANGPTL3 |
UniProt Entry Name: | ANGL3_HUMAN |
As the OD values of the standard curve may vary according to the conditions of the actual assay performance (e. g. operator, pipetting technique, washing technique or temperature effects), the operator should establish a standard curve for each test. Typical standard curve and data is provided below for reference only.
Concentration (ng/mL) | O.D | Average | Corrected |
50 | 2.585 2.506 | 2.546 | 2.486 |
25 | 1.679 1.66 | 1.67 | 1.61 |
12.5 | 0.958 0.921 | 0.94 | 0.88 |
6.25 | 0.498 0.504 | 0.501 | 0.441 |
3.13 | 0.262 0.272 | 0.267 | 0.207 |
1.57 | 0.189 0.181 | 0.185 | 0.125 |
0.78 | 0.118 0.113 | 0.116 | 0.056 |
0 | 0.062 0.058 | 0.06 | -- |
Precision
Intra-assay Precision (Precision within an assay): 3 samples with low, mid range and high level Human ANGPTL3 were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, mid range and high level Human ANGPTL3 were tested on 3 different plates, 20 replicates in each plate.
Intra-assay Precision | Inter-assay Precision | |||||
Sample | 1 | 2 | 3 | 1 | 2 | 3 |
n | 20 | 20 | 20 | 20 | 20 | 20 |
Mean (ng/mL) | 2.40 | 5.48 | 21.14 | 2.23 | 5.41 | 21.84 |
Standard deviation | 0.13 | 0.26 | 0.94 | 0.12 | 0.26 | 1.04 |
C V (%) | 5.42 | 4.74 | 4.45 | 5.38 | 4.81 | 4.76 |
Recovery
The recovery of Human ANGPTL3 spiked at three different levels in samples throughout the range of the assay was evaluated in various matrices.
Sample Type | Range (%) | Average Recovery (%) |
Serum (n=5) | 96-105 | 100 |
EDTA plasma (n=5) | 94-104 | 99 |
Cell culture media (n=5) | 98-109 | 101 |
Linearity
Samples were spiked with high concentrations of Human ANGPTL3 and diluted with Reference Standard & Sample Diluent to produce samples with values within the range of the assay.
Serum (n=5) | EDTA plasma (n=5) | Cell culture media (n=5) | ||
1:2 | Range (%) | 98-108 | 88-100 | 99-105 |
Average (%) | 105 | 92 | 102 | |
1:4 | Range (%) | 83-98 | 91-100 | 96-106 |
Average (%) | 91 | 95 | 101 | |
1:8 | Range (%) | 92-104 | 92-102 | 92-101 |
Average (%) | 97 | 96 | 97 | |
1:16 | Range (%) | 89-102 | 91-102 | 86-98 |
Average (%) | 94 | 98 | 92 |
An unopened kit can be stored at 4°C for 1 month. If the kit is not used within 1 month, store the items separately according to the following conditions once the kit is received.
Item | Specifications | Storage |
Micro ELISA Plate(Dismountable) | 8 wells ×12 strips | -20°C, 6 months |
Reference Standard | 2 vials | |
Concentrated Biotinylated Detection Ab (100×) | 1 vial, 120 µL | |
Concentrated HRP Conjugate (100×) | 1 vial, 120 µL | -20°C(shading light), 6 months |
Reference Standard & Sample Diluent | 1 vial, 20 mL | 4°C, 6 months |
Biotinylated Detection Ab Diluent | 1 vial, 14 mL | |
HRP Conjugate Diluent | 1 vial, 14 mL | |
Concentrated Wash Buffer (25×) | 1 vial, 30 mL | |
Substrate Reagent | 1 vial, 10 mL | 4°C(shading light) |
Stop Solution | 1 vial, 10 mL | 4°C |
Plate Sealer | 5 pieces | |
Product Description | 1 copy | |
Certificate of Analysis | 1 copy |
- Set standard, test sample and control (zero) wells on the pre-coated plate and record theirpositions. It is recommended to measure each standard and sample in duplicate. Note: addall solutions to the bottom of the plate wells while avoiding contact with the well walls. Ensuresolutions do not foam when adding to the wells.
- Aliquot 100 µL of standard solutions into the standard wells.
- Add 100 µL of Sample / Standard dilution buffer into the control (zero) well.
- Add 100 µL of properly diluted sample (serum, plasma, tissue homogenates and otherbiological fluids) into test sample wells.
- Cover the plate with the sealer provided in the kit and incubate for 90 min at 37 °C.
- Aspirate the liquid from each well, do not wash. Immediately add 100 µL of BiotinylatedDetection Ab working solution to each well. Cover the plate with a plate seal and gently mix. Incubate for 1 hour at 37 °C.
- Aspirate or decant the solution from the plate and add 350 µL of wash buffer to each welland incubate for 1-2 minutes at room temperature. Aspirate the solution from each well andclap the plate on absorbent filter paper to dry. Repeat this process 3 times. Note: a microplatewasher can be used in this step and other wash steps.
- Add 100 µL of HRP Conjugate working solution to each well. Cover with a plate seal andincubate for 30 min at 37 °C.
- Aspirate or decant the solution from each well. Repeat the wash process for five times asconducted in step 7.
- Add 90 µL of Substrate Reagent to each well. Cover with a new plate seal and incubate forapproximately 15 min at 37 °C. Protect the plate from light. Note: the reaction time can beshortened or extended according to the actual color change, but not by more than 30min.
- Add 50 µL of Stop Solution to each well. Note: Adding the stop solution should be done inthe same order as the substrate solution.
- Determine the optical density (OD value) of each well immediately with a microplate readerset at 450 nm.